☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Metastatic Esophageal Squamous Cell Carcinoma (ESCC)
BMS' Opdivo (nivolumab) Receives EC's Approval as 2L Treatment for Unresectable Advanced and Metastatic Esophageal Squamous Cell C...
November 25, 2020
Load more...
Back to Home